sumi.news
Search
Following
Sign in
← Back to news
S
Seeking Alpha: Popular
RSS Feed
seekingalpha.com
seekingalpha.com/listing/most-popular-articles.xml
Follow
Latest
Sat Dec 13
What The Micron Bulls Would Have You Believe Is Insane
1w
S
The Best Mid-Caps May Achieve 'Sweet Spot' Status In 2026
1w
S
Outlook For 2026: Three Reasons I Am Preparing For A Correction
1w
S
The One Retirement Risk Too Few Care About, And How Dividends Fix It
1w
S
30%+ Total Returns In 2025: Embrace Our 3 High-Income Momentum Picks For 2026
1w
S
Don't Buy Sucker Yields - Here Are 3 Of My Favorite 9% Dividend Picks
1w
S
Celestica: I've 3xed My Investment But I'm Still Buying More
1w
S
Energy Transfer: Lake Charles Shock, EBITDA Miss And A Bearish Rollover Into 2026
1w
S
CoreWeave Selloff Ignores Agentic AI Compute Floor
1w
S
Ares Capital: Resetting Expectations In A Lower-Rate Cycle
1w
S
Super Micro's Most Mispriced Phase
1w
S
Abercrombie & Fitch: This Is Just The Beginning
1w
S
GE Vernova: Positioning To Power The AI Revolution
2w
S
Archer Aviation's Meltdown Triggers Buy Opportunity - Promising 2026 Monetization (Rating Upgrade)
2w
S
Eaton: Powerful Growth Play But Still Expensive
2w
S
Politics And The Markets 12/30/25
2w
S
If I Could Retire With Only 3 Dividend Growth Investments
2w
S
Where To Find Outperformance In 2026
2w
S
MLPI: NEOS Knows How To Surprise Income Investors
2w
S
3 REITs To Buy Before Their Dividends Surge
2w
S
3 Fat Years, 3 Lean Years
2w
S
The 2026 Playbook Every Investor Needs - And How I'm Executing It
2w
S
S&P 7,500-Plus Or Bust? Our 2026 Outlook For Income Investors
2w
S
Wall Street Breakfast - Year In Review
2w
S
Wall Street Breakfast Podcast: Costly Click For Coupang
2w
S
3 REITs To Ascend In 2026
2w
S
Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026
2w
S
Broadcom: TPUs And Tomahawks Make It A Top Trade For 2026
2w
S
Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (Rating Upgrade)
2w
S
American Water Works: Large Potential, Large Capex Challenges
2w
S
Iovance Biotherapeutics: Bright Prospects For 2026
2w
S
Hercules Capital: Pay The BV Premium And Be Done With It
2w
S
Politics And The Markets 12/29/25
2w
S
Automate Your Income Machine: Dividend Growers Built For Any Market
2w
S
Market Outlook 2026: Technology, Precious Metals, And Commodities
2w
S
These 10 ETFs Are My 'Core' Heading Into 2026, How I'm Using Them
2w
S
2 Once-In-A-Decade Buying Opportunities For 2026
2w
S
Wall Street Week Ahead
2w
S
How I'm Betting Big On A High-Growth, High-Inflation World
2w
S
Broadcom: Aggressive Revisions Justify Strong Buy Upgrade
2w
S
Broadcom: One Of Our Favorite Picks For 2026 In The Semiconductor Universe
2w
S
CoreWeave Has Dramatically Further To Fall
2w
S
Lumentum Holdings' Momentum Is Enticing, But There Are Too Many Reasons To Stay Away
2w
S
Apple: Quality Vs. Price
2w
S
Microsoft: The AI Utility Thesis - Weighing $392 Billion Backlog Against CapEx Depreciation Cliff
2w
S
Humana: Margin Headwinds To Persist In 2026
2w
S
Pure Storage: The Outlook Is Pure; The Valuation Far Less So
2w
S
Be The Bank: I Am Locking In 7% Yields From Corporate And Municipal Borrowers Now
2w
S
Retirement Income And 10%+ Yields: No, They Aren't Mutually Exclusive
2w
S
Dividend Cut Alert: Popular 10%+ Yields Getting Risky
2w
S
More →
